NCT07346911

Brief Summary

Some adolescents experience periods of anxiety and/or depression, and some find that these periods return over time. The purpose of this study is to examine whether digital interventions-where individuals work systematically with their own thoughts and feelings during periods when they feel well-can help them maintain well-being for longer. The study includes adolescents aged 16-19 who have previously experienced episodes of depression and/or anxiety to a degree that led them to seek help (e.g., from a school nurse, general practitioner, health clinic, or child and adolescent mental health service). Through a research app on their smartphones, participants complete tasks and answer questionnaires. The study is fully digital. Some participants meet with a therapist in digital group sessions, while others work independently with the digital content. We will also examine the cost-benefit aspects of offering such interventions. If the study achieves its goals, digital interventions may eventually become a service offered to adolescents recovering from depression and anxiety.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
495

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Apr 2026Jun 2027

First Submitted

Initial submission to the registry

December 22, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

December 22, 2025

Last Update Submit

March 12, 2026

Conditions

Keywords

Transdiagnostic interventions

Outcome Measures

Primary Outcomes (2)

  • Relapse: Number of participants scoring above the diagnostic cut-off on the PHQ-9 modified for teens during the 12-month follow-up.

    To use the PHQ-9 as a diagnostic aid for Major Depressive Disorder: * Questions 1 and/or 2 need to be endorsed as a "2" or "3" * Need five or more positive symptoms (positive is defined by a "2" or "3" in questions 1-8 and "1", "2", or "3" in question 9). * The functional impairment question (How difficult….) needs to be rated at least as "somewhat difficult."

    From enrollment to the end of follow-up at 12-months.

  • Time until relapse; reaching the diagnostic criteria of MDD according to PHQ-9 modified for teens

    Number of days until the diagnostic criteria of MDD as assessed PHQ-9 modified for teens has been reached. \- Questions 1 and/or 2 need to be endorsed as a "2" or "3" * Need five or more positive symptoms (positive is defined by a "2" or "3" in questions 1-8 and by a "1", "2", or "3" in question 9). * The functional impairment question (How difficult….) needs to be rated at least as "somewhat difficult."

    From enrollment to 12-months follow-up

Secondary Outcomes (5)

  • Repetitive negative thinking (RNT-10)

    At enrollment, and at 3, 6 and 12 months follow-up

  • Somatic complaints (SSS8)

    At enrollment, and at 3, 6, and 12-months follow-up.

  • EPOCH Measure of Adolescent Well-Being

    At baseline, 3, 6 and 12-months follow-up.

  • Health related quality of life

    At baseline, 3, 6 and 12-months follow-up.

  • Health related quality of life - Visual Analog Scale

    At baseline, 3, 6 and 12-months follow-up.

Other Outcomes (1)

  • Client satisfaction questionnaires (CSQ-I)

    At 3 months follow-up.

Study Arms (3)

App intervention

EXPERIMENTAL

A transdiagnostic, self-guided CBT app: 1. Standardized self-assessment for mental health: 'Test your psychological immune system'. 2. Educational mini-series: A 30-minute, entertaining video series that teaches users to build resilience by addressing essential needs like sleep (psychological immune system), recognizing negative thought patterns (thought viruses), and developing healthier coping mechanisms (psychological vitamins). 3. Daily practice: Over 20 days, users receive a short, 1-2-minute video each morning. These videos provide practical tips, small experiments, or simple tasks designed to help users integrate healthier coping strategies into their daily lives.

Behavioral: Transdiagnostic app intervention

Group intervention

EXPERIMENTAL

A transdiagnostic, mastery course for groups, delivered weekly in webinar format over three sessions. It includes videos and group discussions.

Behavioral: Transdiagnostic mastery course

Assessment only

NO INTERVENTION

Only assessment will be conducted.

Interventions

Group-based webinar offering psychoeducation based on principles of CBT.

Group intervention

A transdiagnostic, self-guided CBT app, called TankeVirus (literally translated Thought Viruses), consisting of three components: 1. Standardized self-assessment for mental health: 'Test your psychological immune system'. 2. Educational mini-series: A 30-minute, entertaining video series that teaches users to build resilience by addressing essential needs like sleep (psychological immune system), recognizing negative thought patterns (thought viruses), and developing healthier coping mechanisms (psychological vitamins). 3. Daily practice: Over 20 days, users receive a short, 1-2-minute video each morning. These videos provide practical tips, small experiments, or simple tasks designed to help users integrate healthier coping strategies into their daily lives.

App intervention

Eligibility Criteria

Age16 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Currently in full or partial remission for a minimum of 2 months from a depressive disorder or an anxiety disorder as defined by self-reported scores on RCADS-47: previous episode(s) of t-score \> 65 and current t-score =\<65.
  • Native or fluent Scandinavian language skills.
  • Willingness to take part even when allocated to the non-preferred arm of the trial.

You may not qualify if:

  • Ongoing depressive disorder, ongoing anxiety disorder as defined by current t-score =\<65 on RCADS-47.
  • Recent completion of one of the interventions in the two interventional arms.
  • no available smartphone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oslo

Oslo, Norway

Location

Related Links

MeSH Terms

Conditions

Anxiety DisordersPhobic Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 16, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The dataset underlying the results will be shared together with publications.

Locations